| Company Name: |
Hubei Xinyang Medical Technology Co., Ltd
|
| Tel: |
15347293736 |
| Email: |
2853117764@yongstandards.com |
| Products Intro: |
Product Name:R-Erythro-taxotere CAS:133577-32-9 Purity:99% HPLC Package:10mg;25mg;50mg;100mg;200mg;500mg
|
| Company Name: |
Shenzhen Roark Pharma-Tec Co., Ltd.
|
| Tel: |
13128912434 |
| Email: |
2880126944@qq.com |
| Products Intro: |
Product Name:Docetaxel Impurity 25 CAS:133577-32-9 Purity:99% HPLC Package:10MG;25MG;50MG;100MG
|
|
| | R-Erythro-taxotere Basic information |
| Product Name: | R-Erythro-taxotere | | Synonyms: | R-Erythro-taxotere;2R, 3R- Docetaxel (3'-epi-docetaxel);Benzenepropanoic acid, β-[[(1,1-dimethylethoxy)carbonyl]amino]-α-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βR...;Paclitaxel Impurity 62;2R,3R-Docetaxel;(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-9-(((2R,3R)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl Benzoate | | CAS: | 133577-32-9 | | MF: | C43H53NO14 | | MW: | 807.89 | | EINECS: | | | Product Categories: | | | Mol File: | 133577-32-9.mol |  |
| | R-Erythro-taxotere Chemical Properties |
| Boiling point | 900.5±65.0 °C(Predicted) | | density | 1.37±0.1 g/cm3(Predicted) | | pka | 11.20±0.46(Predicted) |
| | R-Erythro-taxotere Usage And Synthesis |
| Uses | (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-Acetoxy-9-(((2R,3R)-3-((tert-butoxycarbonyl)amino)-2-hydroxy-3-phenylpropanoyl)oxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-12-yl Benzoate is a synthetic analogue of Paclitaxel (P132500), an antineoplastic of clinical interest for its activity in inhibiting microtubule disassembly and potency to treat lung, ovarian, breast cancer, and advanced forms of Kaposi''s sarcoma. |
| | R-Erythro-taxotere Preparation Products And Raw materials |
|